The main purine analogues with activity against lymphoid malignancies are fludarabine, cladribine and pentostatin, all of which are active against slowly proliferating cells through their inhibition of DNA repair and therefore have significant synergistic activity with cytotoxic agents which cause D
The role of purine analogue combinations in the management of acute leukemias
β Scribed by R. J. Frewin; S. A. Johnson
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 64 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0278-0232
- DOI
- 10.1002/hon.686
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Cytosine arabinoside plays a pivotal role in the therapy of acute myeloid leukemias with the concentration of its active metabolite, araβCTP, being positively correlated with improved clinical outcome. Both in vitro studies and ex vivo studies have confirmed the ability of the purine analogues to enhance araβCTP accumulation within leukemic cells via the stimulation of deoxycytidine kinase. Clinical studies have confirmed the efficacy of these combination regimes in the treatment of acute leukemias.
βThe basis of the biochemical rationale for the development of combination chemotherapy regimes with purine analogues for acute leukemias is reviewed along with clinical studies of their effectiveness and toxicity. Copyright Β© 2001 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract ## Background Antimetaboliteβbased continuation therapy is commonly used for childhood acute lymphoblastic leukemia (ALL) and hypoglycemia after prolonged fasting has been recently reported. We have found that spontaneous, symptomatic hypoglycemia (SH) may also occur in such patients.
## Abstract We retrospectively studied intravenous urograms (IVU) performed at presentation on 108 children with acute leukemia in order to determine whether any association existed between an abnormal IVU and known prognostic factors at presentation, initial renal function, and outcome. Sixteen pa